Effect of Materials for Subcuticular Suture (Quill vs. Monocryl) on Complications After Liver Resection
2 other identifiers
observational
40
1 country
1
Brief Summary
This study investigates the effect of materials used in subcuticular suture on patients' outcomes after surgery. The prevention of surgical site wound infection is important to decrease the length of hospital stay and the post-operative risk of incisional hernia, especially in patients undergoing open hepatectomy (surgical removal of the liver). The purpose of this study is to compare the impact of the use of Quill versus Monocryl for subcuticular suture on patients' outcomes after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2021
CompletedFirst Submitted
Initial submission to the registry
May 12, 2021
CompletedFirst Posted
Study publicly available on registry
May 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedApril 12, 2023
April 1, 2023
2.7 years
May 12, 2021
April 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of complications after liver resection
The impact of materials for subcuticular suture (Quill versus Monocryl) on complications after liver resection will be evaluated.
1 year
Study Arms (1)
Observational (medical record review)
Patients' medical records are reviewed retrospectively.
Interventions
Medical records are reviewed
Eligibility Criteria
Patients undergoing liver resection at MD Anderson Cancer Center from June 1, 2020 through January 31, 2021
You may qualify if:
- Patients \>= 18 years of age undergoing liver resection at MD Anderson Cancer Center from June 1, 2020 through January 31, 2021
You may not qualify if:
- Patients who have a history of previous abdominal surgery will be excluded
- Pregnant women will not be included in this chart review
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Nicolas Vauthey
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2021
First Posted
May 28, 2021
Study Start
April 10, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
April 12, 2023
Record last verified: 2023-04